technologynetworks25 分钟
CAR T-Cell Therapy Shows Promise in Preclinical Models of HER2-Positive Solid Tumors
T therapy targeting p95HER2 shows complete and durable tumor responses in HER2+ breast cancer preclinical models. Combining ...